Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Evolving Toward Empowerment: How We Are Deepening Relationships With Patients

Multilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients.

Women With Natural Menopause at a Later Age May Have an Increased Risk of Asthma

A recent study published in the Menopause Society’s journal, Menopause, shows that later age at the time of natural menopause onset is associated with a greater risk for asthma. Women aged 40 to 44 years at the time of natural menopause showed about a 30% decreased risk for asthma incidence.

Novartis Lifts Outlook, Citing Cancer and Inflammatory Drugs

Novartis AG raised its medium-term sales target, citing upbeat expectations for new cancer and immunological disease medicines, as well as treatments for neurological and cardiovascular conditions.

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

Novotech has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.

ACTO on LinkedIn

This piece featuring Sanofi authors disussing the positive impact of #AI across many different areas of a business.

#pharma

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs